Our distinguished panel of judges will hear argument from both sides—petitioners and the government—and make a decision regarding the legality of marijuana’s continued classification as a Schedule I substance. Come see the exciting hearing unfold!
This is the final installment of INCBA’s Business Law - Formation series. This panel will discuss the nuts and bolts of raising money including, securities laws, what is a security, registration requirements, exemptions to registration, types of investment vehicles, and investor disclosure documents.
This panel will address current and emerging challenges surrounding such methods and new products from the business, legal, and regulatory perspectives. Topics will include the vaping crisis, regulation of novel delivery systems, hardware inputs and related supply chain matters, various approaches to the regulation of edibles, hemp, and hemp-derived CBD, and what the future may hold.
The panel will focus on the regulations applicable to foodstuff in the US, Mexico, Colombia and Chile. In particular, we will discuss different regulations in connection to dietary supplements, nutraceuticals, advertisement and further challenging issues for the industry, to later focus on the approach that these regulations have regarding the use of hemp in foodstuff products and future challenges in this regard.
Since 2014, Americans For Safe Access’s annual State of the States report has assessed the strength of medical cannabis programs by assigning grades to each of the 50 states, the District of Columbia and the U.S. territories. The 2021 Americans for Safe Access State of the States Report will feature new report card formats and scoring that highlight key areas of medical cannabis policy that affect patient needs.
This program will address current trends in cannabis securities litigation. Participants can expect to receive information on a variety of cannabis-related securities cases, including the most recent of such cases, which was filed in April 2022. Participants will learn about the current strategies taken in securities actions through cases at varying stages of litigation.
Upon completion of this program, participants should expect to be able to identify common causes of action levied against cannabis-related entities and strategies those entities can implement to mitigate risk.
This panel will provide real life practical solutions to the question the cannabis industry faces: how do we level the playing field in a highly regulated, highly competitive industry? We will discuss how to practically implement social equity efforts beyond what states and municipalities have been offering and discuss recommendations for federal legalization.